Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RCEL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
RCEL stock price ended at $6.28 on Friday, after losing-1.88%
The AVITA Medical Inc stock price decreased by -1.88% on the last trading day (23 May 2025), dropping from 6.35 to 6.28. Throughout the last trading session, the stock experienced a fluctuation of 6.38% , ranging from a day low of $6.19 to a day high of 6.585. The price has declined in 7 of the last 10 days, resulting in a total change of -9.90% during this period. On the last day, trading volume increase by -46.05K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 179.14K shares were traded, amounting to approximately 1.12M.
RCEL Technical Signals
RCEL(AVITA Medical Inc Corp) has 4 buy signals and 3 sell signals now. The current trend is downtrend starting from 2025-04-15. The total price change during this trend is -31.96%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of RCEL over the last 5 trading days is 1.26M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
RCEL Moving Average Analysis
AVITA Medical Inc's overall moving average trend leans more bearish as of Saturday, May 24, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $7.525889733333334, and $8.007133333333334. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $5.968776933333333, and $5.487533333333333. A break-down below any of these levels will issue sell signals.
RCEL Short Selling Analysis
The short sale ratio of AVITA Medical Inc(RCEL) as of 16 May 2025 is 26.38%, dropping from last trading day. With decreasing price from 6.37 to 6.46. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Neutral
Sell
3
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Relative Strength Index (14 days)
RSI_14 < 30
28.875
Bullish
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
6.256
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
11.733
Bullish
Williams %R (14 days)
WILLR_14 < -80
-97.009
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-1.797
Bearish
Momentum (10 days)
MOM_10 < 0
-0.69
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.734
Bearish
RCEL Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to AVITA Medical Inc(RCEL), our algorithm predicts RCEL's 1-month price at $6.29, with an -2.57%downwardshift. Using a similarity score up to 97.62%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for AVITA Medical Inc (RCEL.O) stock, as of Sunday, May 18, 2025 , forecasts a -2.57% change over the next month, based on its high correlation with SEE.N stock patterns. The similarity between their price movements over the analyzed periods is 97.62%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
RCEL
Future prediction
Up: -2.57%
SEE
Down: -2.57%Similarity: 97.62%
Name
Similarity
Up/Down
SEE.N
97.62%
-2.57%
HKIT.O
97.15%
+94.52%
UNP.N
97.12%
+14.95%
JWEL.O
97.09%
-29.84%
GOOG.O
96.86%
-1.44%
GOOGL.O
96.86%
-1.44%
FTNT.O
96.84%
-6.06%
TSAT.O
96.81%
-7.62%
AAL.O
96.79%
+20.06%
DAKT.O
96.77%
-4.86%
RCEL Seasonality Analysis
Based on RCEL's historical stock price data across all years, the probability of a positive return in May is36.36%, suggesting it maynotbe an ideal month to invest in RCEL. In contrast,Novemberoffers the highest probability of positive returns at70.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying AVITA Medical Inc (RCEL.O) stock in November has the highest probability of a positive return (70.00%), while October has the lowest probability (30.00%).
Performance Seasonality
The chart shows AVITA Medical Inc. (RCEL)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RCEL has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying AVITA Medical Inc (RCEL.O) stock in a year?
The radar chart shows that buying AVITA Medical Inc (RCEL.O) stock in November has the highest probability of a positive return (70.00%), while October has the lowest probability (30.00%).
How has AVITA Medical Inc. (RCEL)'s stock price performed over the past three years?
RCEL's stock price rose by 112.71% in 2023,decreased by -5.74% in 2024, and went down by 50.9% in 2025.
Is RCEL a buy based on overall technical signals summary?
RCEL has 4 buy signals and 3 sell signals now. Overall the technical rating for RCEL is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of RCEL.
What is the trend of AVITA Medical Inc (RCEL)'s moving average?
AVITA Medical Inc's overall moving average trend leans more bearish as of May 24 2025, with 4 negative signals and 0 positive signal.
What is price prediction for RCEL stock next month?
The price prediction chart for AVITA Medical Inc (RCEL.O) stock, as of May 18 2025, forecasts a -2.57% change over the next month, based on its high correlation with SEE stock patterns. The similarity between their price movements over the analyzed periods is 97.62%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for RCEL Stock?
RCEL stock is expected to reach **$9.50 by Q4 2025**, driven by strong revenue growth and new product launches. The stock is currently undervalued with a price target of **$17.40**, supported by positive insider sentiment and expanding market opportunities. Immediate support is at **$6.50**, making it a good entry point for long-term growth.
What is price prediction 2030 for RCEL Stock?
### **Price Prediction for RCEL Stock by 2030**
Based on current trends and analysis, RCEL stock could reach **$20-$25 by 2030**, driven by its expanded product portfolio and strong revenue growth. However, if challenges arise, the price may stabilize around **$15-$18**.
**Reasons:**
- **Growth Drivers**: RCEL is transforming into a leader in acute wound care with new products like RECELL GO mini and Cohealyx, targeting a $3.5B market.
- **Financial Outlook**: Projected 55%-65% revenue growth in 2025 and expected profitability by Q4 2025.
- **Analyst Sentiment**: Average price target of $17.40 with a Moderate Buy consensus.